Comparative efficacy of two different topical povidone-iodine 5% regimens in reducing conjunctival bacterial flora: A randomized parallel double-masked clinical trial

被引:5
|
作者
Barroso, Leticia Fernandes [1 ]
Cazella, Sarah Pereira [1 ]
Nepomuceno, Antonio Brunno [1 ]
Toscano, Luiza [1 ]
de Souza Castilho, Liliane Angela [1 ]
Rueda Furlan, Eloisa Marcela [1 ]
Messias, Andre [1 ]
Scott, Ingrid U. [2 ,3 ]
Jorge, Rodrigo [1 ]
机构
[1] Univ Sao Paulo, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, Sch Med Ribeirao Preto, Ribeirao Preto, SP, Brazil
[2] Penn State Coll Med, Dept Ophthalmol, Hershey, PA USA
[3] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA
来源
PLOS ONE | 2017年 / 12卷 / 12期
基金
巴西圣保罗研究基金会;
关键词
ACUTE POSTOPERATIVE ENDOPHTHALMITIS; CHEMICAL PREPARATION; CATARACT-EXTRACTION; OPHTHALMIC SURGERY; ANTIBIOTICS; RESISTANCE; EYE; PROPHYLAXIS; PREVENTION; ANTISEPSIS;
D O I
10.1371/journal.pone.0189206
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction The increasing prevalence of multi-resistant bacteria is a major public health concern. Infections acquired during ophthalmic surgery are devastating. The purpose of the current study is to compare the proportion of eyes with negative bacterial cultures on all tested media after 1 versus 3 sequential drops of povidone-iodine (PI) 5% into the inferior conjunctival fornix. Methods Patients were randomly assigned to receive 1 (PI group) drop (at time 28 minutes) or 3 (PI plus group) sequential drops (at time 0, 20 minutes and 28 minutes) of PI 5% into the inferior conjunctival sac of one randomly selected eye. A swab culture was obtained from the inferior conjunctival fornix 5 minutes before and 30 minutes after time 0. Central corneal thickness (CCT) was measured shortly before time 0 and shortly after time 30. Conjunctival swabs were incubated aerobically in enriched Thioglycolate liquid medium (meat broth) and in three solid culture media (chocolate agar, trypticase soy agar with 5% sheep blood, and Sabouraud agar). Results There was no significant difference in the proportion of negative cultures after intervention between groups (p = 0.1638). Also in the PI group (n = 59), the proportion of eyes with negative cultures after PI (79.7%) did not differ significantly from baseline (76.3%; p = 0.7539). However in the PI plus group (n = 61), the proportion of eyes with all negative cultures after PI (85.3%) was significantly higher than before PI (70.5%) (p = 0.0177). There was no significant difference in mean CCT before and after the intervention in both groups. Conclusion Instillation of 3 sequential drops of PI was associated with a significant increase in the proportion of eyes with all negative cultures, while instillation of a single drop of PI was not associated with a significant increase in the proportion of negative cultures. Further study is warranted to determine whether the difference between the PI administration regimens is also associated with differences in the rates of postoperative ocular infections.
引用
收藏
页数:12
相关论文
共 26 条
  • [11] Efficacy and tolerability of a fixed-dose moxifloxacin - dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial
    Campos, Mauro
    Avila, Mariana
    Wallau, Anelise
    Muccioli, Cristina
    Hoefling-Lima, Ana Luisa
    Belfort, Rubens, Jr.
    CLINICAL OPHTHALMOLOGY, 2008, 2 (02): : 331 - 338
  • [12] Clinical efficacy of topical nipradilol and timolol on visual field performance in normal-tension glaucoma: A multicenter, randomized, double-masked comparative study
    Araie, Makoto
    Shirato, Shiroaki
    Yamazaki, Yoshio
    Kitazawa, Yoshiaki
    Ohashi, Yasuo
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2008, 52 (04) : 255 - 264
  • [13] Clinical efficacy of topical nipradilol and timolol on visual field performance in normal-tension glaucoma: a multicenter, randomized, double-masked comparative study
    Makoto Araie
    Shiroaki Shirato
    Yoshio Yamazaki
    Yoshiaki Kitazawa
    Yasuo Ohashi
    Japanese Journal of Ophthalmology, 2008, 52 : 255 - 264
  • [14] Prospective, Randomized, Double-Masked Clinical Trial Comparing Safety and Efficacy of Topical Tacrolimus vs. Methylprednisolone for Ocular Graft-Versus-Host Disease
    Saboo, Ujwala Sachin
    Abud, Tulio
    Amparo, Francisco
    Ciolino, Joseph B.
    Hamrah, Pedram
    Dana, Reza
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [15] A Randomized, Double-Masked, Parallel- Group, Phase 2a Dry Eye Disease Clinical Trial to Evaluate the Safety and Efficacy of Topical Ocular ADX-102, a Novel Aldehyde Sequestering Agent
    Clark, David
    Ousler, George W.
    Hollander, David
    Brady, Todd
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [16] Reducing Adenoviral Patient-Infected Days (RAPID) Study: A Randomized Trial Assessing Efficacy of One Time, In-Office Application of 5% Povidone-Iodine in Treatment of Adenoviral Conjunctivitis
    Hartwick, Andrew
    Than, Tammy
    Rodic-Polic, Bojana
    Johnson, Spencer
    Migneco, Mary
    Shorter, Ellen
    Harthan, Jennifer S.
    Morettin, Christina
    Whiteside, Meredith
    Olson, Christian K.
    Margolis, Mathew
    Huecker, Julia
    Storch, Gregory
    Gordon, Mae O.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [17] A randomized double-masked clinical trial to assess the safety and comparative efficacy of three concentrations of a cyclosporine-containing ophthalmic ointment vs placebo in patlents with keratoconjunctivitis SICCA (KCS)
    Helms, HA
    Rapoza, P
    Stern, KL
    Burk, CT
    Rosenthal, A
    Reis, BL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 2993 - 2993
  • [18] Efficacy and safety of besifloxacin ophthalmic suspension 0.6 in children and adolescents with bacterial conjunctivitis: A post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials
    Comstock T.L.
    Paterno M.R.
    Usner D.W.
    Pichichero M.E.
    Pediatric Drugs, 2010, 12 (2) : 105 - 112
  • [19] Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled Phase 2b Dry Eye Disease Clinical Trial to Evaluate Safety and Efficacy of Topical Ocular Reproxalap, a Novel RASP Inhibitor
    Sheppard, John D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [20] Efficacy and Side Effects of Topical Applications of Two Different Solutions in the Treatment of Molluscum Contagiosum in a City in Africa: An Open, Randomized, Comparative Clinical Trial
    Ozturk, Melike Kibar
    JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, 2019, 14 (05) : 248 - 252